Equities
Graham Holdings Declares $1.88 Quarterly Dividend
The Arlington, Virginia-based company said the dividend will be paid on Nov. 5, 2026 to shareholders of record on Oct. 15, 2026.
BioMarin Expands Growth Strategy Beyond VOXZOGO with Pipeline Expansion
BioMarin Pharmaceutical Inc. outlined a broader growth plan at the Cantor Fitzgerald Global Healthcare Conference, highlighting new clinical assets and international expansion opportunities beyond its lead product VOXZOGO.
American Tower Projects 2027 Growth as 5G Cycle Inflects
U.S. tower company forecasts mid-single-digit AFFO growth, margin expansion and FX/rate headwinds in outlook beyond 2026
4D Molecular Therapeutics Eyes Wet AMD Breakthrough with Gene Therapy 4D-150
The biotech aims to disrupt wet age-related macular degeneration with a novel aflibercept-expressing gene therapy, targeting a paradigm shift in treatment burden and persistence challenges.
Travere Therapeutics Stock Hits 52-Week High on Strong Q2 Earnings
Travere Therapeutics shares peaked near an all-year high as second-quarter revenue of $169.6 million topped forecasts, driven by a near-doubling in FILSPARI sales.
SMI opens higher; Fed rate-hike odds near 93% as traders wait for Wednesday decision
The Swiss benchmark rose 0.1% to 13,815.84 as ABB led gainers. Investors stayed cautious ahead of the Federal Reserve's rate decision, where a 25-bp hike is priced in at over 90%.
Rokmaster Acquires 100% Stake in Chile's Cristal Copper Project
The TSXV-listed miner satisfied initial option terms to take full control of a porphyry copper property in northern Chile, offering 7 million shares and $70,000.
Swiss Stocks rebound early week; Roche, Novartis lead, ABB and tech drag
The SMI rose 0.6% to 13,854 in a first countermove after last week's >4% slide. Pharmaceutical giants led gains while AI-linked and construction-materials names faced pressure from rising Brent crude above $107.
Braze Raises Operating Margin Guidance Amid AI Acceleration
Braze’s CEO highlights AI-driven growth and early hiring push to bolster 2025 revenue, despite trailing losses and seasonal revenue pressures.
Mizuho Cuts PG&E Price Target to $14 After Utility Trims 2027 Capex
PG&E slashed its 2027 capital spending by $2 billion to $11.4 billion as wildfire liability reforms stalled in California, prompting Mizuho and other banks to lower their outlook.
Stifel Raises Snowflake Price Target to US$450 Amid AI-Driven Growth
Snowflake Inc. saw its price target rise to US$450 from US$350 as analysts highlight accelerating AI adoption and robust client growth.
Five Below Raises Price Target to US$295 Amid Strong Q2 Fiscal 2026 Results
Analysts raised expectations for Five Below Inc. after the retailer reported robust Q2 fiscal 2026 earnings and revised guidance upward, citing sustained comparable sales growth and operational resilience.
Russia shares close lower, MOEX index flat
Russian equities fell at the Moscow close on Sunday while the MOEX Russia Index held steady. Declining stocks outnumbered gainers 133 to 99, with modest moves in major shares, commodities and currencies.
Schweizer Aktienmarkt erholt sich nach Vorwochenverlust: Roche, Novartis dominieren
Der SMI steigt um 0,6 % auf 13.854 Punkte, während KI-Aktien und Bauwerte unter Druck bleiben. Analysten revidieren Kursziele für Roche und Straumann, während Ölpreise und Fed-Zinsentscheidungen die Märkte prägen.
AI Warnings from US Hit Swiss Stocks as SoftBank Plunges
OpenAI's delayed IPO and Anthropic's safety alarms spooked markets Monday, dragging down Japanese tech giant SoftBank over 13% and pressuring Swiss shares across semiconductors and data-center plays.
US indices close out a flat week with modest gains for the S&P 500 and DJIA
US equity indexes ended the week little changed, with the S&P 500 and Dow Jones Industrial Average posting modest gains.
Evolution Metals Forecasts $400‑460M Revenue by 2027
The company projects 2027 revenue between $400 million and $460 million as it scales magnet production and expands power capacity at its Pohang site. It also notes a conditional $20.7 million grant from Korean authorities and expects 2026 revenue of $5 million to $8 million.
Vishay Launches Bidirectional TVS for Automotive Powertrain Protection
The company introduces a new series of transient voltage suppressors designed to safeguard advanced automotive systems, including ADAS and battery management units.
US Futures Rise as Brent Surges Past $100 Ahead of Oracle, Adobe Earnings
Stock futures gained on Thursday even as Brent crude topped $100 a barrel and the 10-year Treasury yield hit its highest level since 2023, with Oracle and Adobe set to report.
Artisan Partners Seeks Board Changes at Novartis After Trial, Acquisition Setbacks
Major shareholder Artisan Partners has called for a board shake-up at Swiss drugmaker Novartis citing recent clinical trial disappointments and failed acquisitions.
GSK's Ris-Rez cuts death risk 54% in relapsed small cell lung cancer trial
Risvutatug rezetecan doubled median overall survival versus topotecan in the ARTEMIS-008 phase III study, with pivotal EMBOLD data expected in 2027.
ADF Group Misses Q2 2026 Profit Expectations, Shares Drop 7%
ADF Group Inc. reported a sharp earnings shortfall in Q2 2026, with revenue growth outpacing expectations but profitability falling short of forecasts, prompting a 7% premarket decline in its shares.
Faeth Therapeutics Highlights Oral PI3K/AKT Pathway Inhibition in Phase I-B Data
Faeth Therapeutics presented Phase I-B results for its dual-oral PI3K inhibitor PIKTOR at the September 2026 Cantor Fitzgerald Healthcare Conference, showing a 47% overall response rate and a pharmacokinetic advantage over intravenous competitors.
Goldplat declares 0.87p special dividend amid excess cash assessment
The mining-services company says £1.5 million in surplus liquidity will be returned to shareholders, with payment due mid-October.